Royal Philips NV shares rose in early European trading after the Dutch medical technology company reported stronger profitability in the third quarter, driven by solid sales across its entire business.
The company said its adjusted EBITA margin improved by 0.7 percentage points year on year to 13%. Higher sales revenue, better gross margins and improved production efficiency offset pressure from cost inflation.
In early European trading, shares of Royal Philips NV (NYSE: PHG) climbed 6.6%.
Nathalie Webster, an analyst at RBC Capital Markets, said in a research note that the margin figures were strong and eased market concerns over whether Philips could meet its full-year margin target.
Third-quarter sales rose to 4.39 billion euros (about 4.91 billion U.S. dollars) from 4.3 billion euros a year earlier.
On Tuesday, Philips said it aims to fully move past the shadow of its sleep respiratory device recall. The company said its Respironics subsidiary has reached an agreement with the U.S. Department of Justice to resolve criminal and civil investigations related to the subsidiary's product recall.
Philips also noted that the Enterprise Chamber of the Amsterdam Court of Appeal this quarter rejected investors' request for further investigation into the matter.
Adjusted EBITA came in at 569 million euros, up from 531 million euros a year earlier. The consensus estimate compiled by the company was 522 million euros.
Net profit, however, fell to 27 million euros from 184 million euros.
Philips reiterated its full-year guidance: comparable sales growth of 3% to 4.5%, and an adjusted EBITA margin of 13.5% to 14.0%.
Comments